[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"prognostic-model\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:prognostic-model":61},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100531233",false,"NCT06197126","MRI-based Signatures for Survival Prediction in Cervical Cancer With Radiotherapy","A Prognostic Model Based on MRI for Cervical Cancer Patients Treated With Radiotherapy","Inclusion Criteria:\n\n* (1) pathologically confirmed CC, (2) initially treated in our center\n\nExclusion Criteria:\n\n* (1) lack of pre-treatment MRI, (2) prior anti-tumor treatment, (3) pelvic surgery history, (4) incomplete therapy, (5) loss of follow-up","FEMALE","20 Years","85 Years",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","This study aims to validate the value of tumor involvement features based on MRI in cervical cancer, facilitate the development of a more appropriate model for risk stratification, and help patients with varying risk profiles make appropriate decisions in treatment selection and follow-up plans.",[24,25,26,27],"Cervical Cancer","Radiotherapy","Prognostic Model","MRI","NOT_YET_RECRUITING","2023-12-25",{"date":31,"type":32},"2024-01-09","ACTUAL",{"date":34,"type":20},"2024-01-01",{"date":36,"type":20},"2028-12-31",{"name":38,"class":39},"Fujian Cancer Hospital","OTHER_GOV",1,{"id":42,"slug":4,"hasResults":10,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":47,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":49,"conditions":50,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":40},"100523919","NCT06101966","A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy","A Novel Predictive Model and Risk Stratification for Early Metastasis in Cervical Cancer Patients After Radiotherapy","Inclusion Criteria:\n\n* patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled\n\nExclusion Criteria:\n\n* (1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials",{"count":48,"type":20},500,"This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.",[24,25,51,26,52],"Distant Metastasis","Risk Factor","2023-10-21",{"date":55,"type":32},"2023-10-26",{"date":57,"type":20},"2023-12-01",{"date":59,"type":20},"2027-12-01",{"name":38,"class":39},""]